A Clinical Study On Prophylactic Iv Oxytocin Infusion At The Time Of Incision In Caesarean Section And Its Outcome In A Tertiary Care Hospital

BACKGROUNDPostpartum haemorrhage remains a significant cause of maternal morbidity and the use of oxytocin has reduced maternal morbidity worldwide. Oxytocin is the uterotonic agent of choice in the prevention and treatment of postpartum uterine atony. Nevertheless, there is no consensus on the optimal dose and rate for use in caesarean sections. As oxytocin helps in uterine contraction, it guides in the easy extraction of baby as well as placental separation.MATERIALS AND METHODSIt is a Descriptive study where 50 women undergoing caesarean section at KIMS, Hubballi, with mentioned exclusion criteria were included in the study. Outcome will be noted based on the difficulty in extraction of baby and placental extraction. RESULTS In around 40 cases baby was extracted without any assistance and in 42 cases placenta expelled on its own. None of the cases were reported with postpartum haemorrhage.CONCLUSIONIV oxytocin infusion during caesarean sections significantly reduces postpartum haemorrhage and helps in baby extraction as well as placental expulsion.